Antigen-specific humoral and cellular immune responses can be modulated in rhesus macaques through the use of IFN-γ, IL-12, or IL-18 gene adjuvants

Journal of Medical Primatology

Volumn 28, Issue 4-5, 1999, Pages 214-223

  Kim, Jong J ^a,c   Nottingham, Liesl K ^a   Tsai, Anthony ^a   Lee, Daniel J ^a   Maguire, Henry C ^a   Oh, Jim ^a   Dentchev, Tzvete ^a   Manson, Kelledy H ^b   Wyand, Michael S ^b   Agadjanyan, Michael G ^a   Ugen, Kenneth E ^b   Weiner, David B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cytokines; DNA vaccines; HIV 1

Indexed keywords

DNA VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 12; INTERLEUKIN 18;

ANIMAL; ANIMAL DISEASE; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ARTICLE; BAGG ALBINO MOUSE; CELLULAR IMMUNITY; DISEASE MODEL; FEMALE; GENETICS; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOLOGY; MACACA; MOUSE; SIMIAN IMMUNODEFICIENCY VIRUS;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; ANTIBODY FORMATION; ANTIGEN-ANTIBODY REACTIONS; DISEASE MODELS, ANIMAL; FEMALE; HIV INFECTIONS; IMMUNITY, CELLULAR; IMMUNIZATION; INTERLEUKIN-12; INTERLEUKIN-18; MACACA MULATTA; MICE; MICE, INBRED BALB C; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, HELPER-INDUCER; VACCINES, DNA;

EID: 0033176724     PISSN: 00472565     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0684.1999.tb00272.x     Document Type: Article

References (31)

1. AGADJANYAN MG, TRIVEDI NN, KUDCHODKAR S, BENNETT M, LEVINE W, LIN A, BOYER J, LEVY D, UGEN K, KIM JJ, WEINER DB: An HIV-2 DNA vaccine induces cross reactive immune responses against HIV-2 and SIV. AIDS Hum Retrovir 13:1561-1572, 1997.
2. ASHERSON GL, PTAK WL: Contact and delayed hypersensitivity in the mouse. 1. Active sensitization and passive transfer. Immunology 15:405-416, 1969.
3. BLOOM ET, HORVATH JA: Cellular and molecular mechanisms of the IL12-induced increase in allospecific murine cytolytic T cell activity: Implications for the age-related decline in CTL. J Immunol 152:4242-4254, 1994.
4. BORROW P, LEWICKI H, HAHN H, SHAW GM, OLDSTONE MBA: Virus specific CD8 + cytotoxic T lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68:6103, 1994.
5. BOYER JD, UGEN KE, WANG B, AGADJANYAN MG, GILBERT L, BAGARAZZI M, CHATTERGOON M, FROST P, JAVADIAN A, WILLIAMS WV, REFAELI Y, CICCARELLI RB, MCCALLUS D, CONEY L, WEINER DB: Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat Med 3:526-532, 1992.
6. CHATTERGOON M, BOYER J, WEINER DB: Genetic immunization: A new era in vaccines and immune therapies. FASEB J 11:753-763, 1997.
7. COFFMAN RL, SEYMOUR BWP, LEBMAN DA, HIRAKI DD, CHRISTIANSEN JA, SHRADER B, CHERWINSKI HM, SAVELKOUL HFJ, FINKELMAN FD, BOND MW, MOSMANN TR: The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev 102:5-28, 1998.
8. DONNELLY JJ, ULMER JB, SHIVER JW, LIU MA: DNA vaccines. Annu Rev Immuol 15:617-648, 1997.
9. FINKELMAN FD, HOLMES J, KATONA IM, URBAN JF, BECKMANN MP, PARK LS, SCHOOLEY KA, COFFMAN RL, MOSMANN TR, PAUL WE: Lymphokine control of in vivo immunoplobulin isotype selection. Ann Rev Immunol 8:303-333, 1990.
10. GATELY MK, WOLITZKY AG, QUINN PM, CHIZZONITE R: Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol 143:127-142, 1992.
11. JIAO S, WILLIAMS P, BERG RK, HODGEMAN BA, LIU L, REPETTO G, WOLFF JA: Direct gene transfer into non-human primate myofibers in vivo. Hum Gene Ther 3:21-33, 1992.
12. KIM JJ, NOTTINGHAM LK, SIN JI, TSAI A, MORRISON L, OH J, DANG K, HU Y, KAZAHAYA K, BENNETT M, DENTCHEV T, WILSON DM, CHALIAN AA, BOYER JD, AGADJANYAN MG, WEINER DB: CD8 positive T cells control antigen-specific immune responses through the expression of chemokines. J Clin Invest 102:1112-1124, 1998.
13. KIM JJ, SIMBIRI KA, SIN JI, DANG K, OH J, DENTCHEV T, LEE D, NOTTINGHAM LK, CHALIAN AA, AGADJANYAN MG, WEINER DB: Cytokine molecular adjuvants modulate immune responses induced by DNA vaccine constructs for HIV-1 and SIV. J Interf Cyto Res 19:77-84, 1999.
14. KIM JJ, WEINER DB: Development of Multi-component DNA vaccination strategies against HIV. Curr Op Mol Therap 1:43-49, 1999.
15. KIM JJ, WEINER DB: DNA/genetic vaccination for HIV. Springer Sem Immunopathol 19:174-195, 1997.
16. KIM JJ, BAGARAZZI ML, TRIVEDI N, HU Y, CHATTERGOON MA, DANG K, MAHALINGAM S, AGADJANYAN MG, BOYER JD, WANG B, WEINER DB: Engineering of in vieo immune responses to DNA immunization via co-delivery of costimulatory molecule genes. Nat Biot 15:641-645, 1997.
17. KIM JJ, AYYVOO V, BAGARAZZI ML, CHATTERGOON MA, DANG K, WANG B, BOYER JD, WEINER DB: In vivo engineering of a cellular immune response by co-administration of IL-12 expression vector with a DNA immunogen. J Immunol 158:816-826, 1997.
18. KIM JJ, TRIVEDI NN, NOTTINGHAM L, MORRISON L, TSAI A, HU Y, MAHALINGAM S, DANG K, AHN L, DOYLE NK, WILSON DM, CHATTERGOON MA, CHALIAN AA, BOYER JD, AGADJANYAN MG, WEINER DB: Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur J Immunol 28:1089-1103, 1998.
19. KOUP RA, SAFRIT JT, CAO Y, ANDREWS CA, MCLEOD G, BORKOWSKY W, FARTHING C, HO DD: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68:4650, 1994.
20. LEKUTIS C, SHIVER JW, LIU MA, LETVIN NL: HIV-1 env DNA vaccine administered to rhesus monkeys elicits MHC class II-restricted CD4 + T helper cells that secrete IFN-gamma and TNF-alpha. J Immunol 158:4471-4477, 1997.
21. LETVIN NL, MONTEFIORI DC, YASUTOMI Y, PERRY HC, DAVIES M-E, LEKUTIS C, ALROY M, FREED DC, LORD CI, HANDT LK, LIU MA, SHIVER JW: Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc Natl Acad Sci USA 94:9378-9383, 1997.
22. MOGENSEN SC, VIRELIZIER JL: The interferon-macrophage alliance (Review). Interferon 8:55-84, 1987.
23. OGG GS, JIN X, BONHOEFFER S, DUNBAR PR, NOWAK MA, MONARD S, SEGAL JP, CAO Y, ROWLAND-JONES SL, CERUNDOLO V, HURLEY A, MARKOWITZ M, HO DD, NIXON DF, MCMICHAEL AJ: Quantitaten of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279:2103-2106, 1998.
24. OKAMURA HHT, KOMATSU T, YUTSUDO M, HAKURA A, TANIMOTO T, TORIGOE K, OKURA T, NUKADA Y, HATTORI K, AKITA K, NAMBA M, TANABE F, KONISHI K, FUKUDA S, KURIMOTO M: Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378:88-91, 1995.
25. PINTO LA, SULLIVAN J, BERZOFSKY JA, CLERICI M, KESSLER HA, LANDAY AL, SHEARER GM: Env-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids. J Clin Invest 96:867-876, 1995.
26. ROBERTSON MJ, SOIFFER RJ, WOLF SF, MANLEY TJ, DONAHUE C, YOUNG D, HERMANN SH, RITZ J: Responses of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med 175:779-788, 1992.
27. ROSENBERG ES, BILLINGSLEY JM, CALIENDO AM, BOSWELL SL, SAX PE, KALAMS SA, WALKER BD: Vigorous HIV-1-specific CD4 + T cell responses associated with control of viremia. Science 278:1447-1450, 1997.
28. ROWLAND-JONES S, SUTTON J, ARIYOSHI K, DONG T, GOTCH F, MCADAM S, WHITBY D, SABALLY S, ALLIMORE A, CORRAH T, TAKIGUCHI M, MCMICHAEL A, WHITTLE H: HIV-specific T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1:59-64, 1995.
29. SEDER RA, PAUL WE: Acquisition of lymphokine-producing phenotypc by CD4 + T cells. Annul Rev Immunol 12:635-673, 1994.
30. TRINCHIERI G: Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate persistence and antigen-specific adaptive immunity. Annul Rev Immunol 13:251-276, 1995.
31. WANG B, BOYER JD, UGEN KE, SRIKANTAN V, AYYAVOO V, AGADJANYAN MG, WILLIAMS WV, NEWMAN M, CONEY L, CARRANO R, WEINER DB: Nucleic acid-based immunization against HIV-1: Induction of protective in vivo immune responses. AIDS 9:S159-S170, 1995.